Genor Biopharma Holdings Limited (6998.HK)

HKD 1.66

(-5.68%)

Operating Expenses Summary of Genor Biopharma Holdings Limited

Genor Biopharma Holdings Limited's latest annual operating expenses in 2023 was 711.19 Million CNY , down -11.23% from previous year.
Genor Biopharma Holdings Limited's latest quarterly operating expenses in 2024 Q2 was 72.09 Million CNY , down 0.0% from previous quarter.
Genor Biopharma Holdings Limited reported a annual operating expenses of 801.15 Million CNY in annual operating expenses 2022, down -10.93% from previous year.
Genor Biopharma Holdings Limited reported a annual operating expenses of 899.51 Million CNY in annual operating expenses 2021, down -3.5% from previous year.
Genor Biopharma Holdings Limited reported a quarterly operating expenses of 72.09 Million CNY for 2024 Q1, down -65.29% from previous quarter.
Genor Biopharma Holdings Limited reported a quarterly operating expenses of 147.89 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Genor Biopharma Holdings Limited (2023 - 2018)

Historical Annual Operating Expenses of Genor Biopharma Holdings Limited (2023 - 2018)

Year	Operating Expenses	Operating Expenses Growth
2023	711.19 Million CNY	-11.23%
2022	801.15 Million CNY	-10.93%
2021	899.51 Million CNY	-3.5%
2020	932.15 Million CNY	79.8%
2019	518.44 Million CNY	84.1%
2018	281.61 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	72.09 Million CNY	0.0%
2024 Q1	72.09 Million CNY	-65.29%
2023 Q2	147.89 Million CNY	0.0%
2023 Q4	207.7 Million CNY	1.2%
2023 Q3	205.24 Million CNY	38.78%
2023 FY	706.27 Million CNY	-11.84%
2023 Q1	147.89 Million CNY	-11.7%
2022 Q3	167.47 Million CNY	-23.47%
2022 Q2	218.83 Million CNY	0.0%
2022 Q1	218.83 Million CNY	-11.31%
2022 FY	801.15 Million CNY	-10.93%
2022 Q4	167.47 Million CNY	0.0%
2021 Q1	197.1 Million CNY	-84.3%
2021 FY	899.51 Million CNY	-3.5%
2021 Q4	246.73 Million CNY	0.0%
2021 Q3	246.73 Million CNY	25.18%
2021 Q2	197.1 Million CNY	0.0%
2020 Q1	142.17 Million CNY	0.0%
2020 Q4	1.25 Billion CNY	0.0%
2020 Q3	1.25 Billion CNY	319.42%
2020 Q2	299.27 Million CNY	110.49%
2020 FY	932.15 Million CNY	79.8%
2019 FY	518.44 Million CNY	84.1%
2019 Q1	74.54 Million CNY	0.0%
2018 FY	281.61 Million CNY	0.0%

Peer Operating Expenses Comparison of Genor Biopharma Holdings Limited

Name	Operating Expenses	Operating Expenses Difference
Uni-Bio Science Group Limited	325.05 Million HKD	-118.796%
CK Life Sciences Int'l., (Holdings) Inc.	739.25 Million HKD	3.796%